Basic and Translational Cancer Research

EPFL research groups

Cathrin Brisken

Breast cancer, mouse genetic, mammary gland development, mouse models, patient derived xenografts, estrogen and progesterone, endocrine disruptors

Michele De Palma

Tumor-associated macrophages, tumor angiogenesis and antiangiogenic therapy Immunotherapy, microRNAs, exosomes and extracellular vesicles, mouse models of cancer, immune cell engineering, lentiviral vector technologies

Douglas Hanahan

Cancer, translational oncology, genetically engineered mouse models of human cancer, tumor microenvironment, angiogenesis, invasion, metastasis, pre-clinical trials

Joerg Huelsken

Tumor heterogeneity and stemness in cancer

Prof. Etienne Meylan

Etienne Meylan

Lung cancer, tumor immune signature, neutrophils, glucose transporters, glucose metabolism, translational oncology

Elisa Oricchio

Cancer genetic, mouse models, therapy, stem cells, lymphoma

Freddy Radtke

Notch, stem and progenitor cells, self-renewing tissues, differentiation, cancer, genetic mouse models

Christoph Merten

Microfluidic technology develpment, single cell analysis, antibody discovery, personalized cancer therapy

Andrea Ablasser

DNA sensing, inflammation, antitumor immunity, cGAS-STING pathway

Affiliated research groups

George Coukos

Tumor immunology, T-cell therapies, cancer vaccines, bioinformatics and engineering, clinical trials

Tatiana Petrova

transcription, differentiation, cancer stem cells, intestinal and vascular development, lymphedema, cancer